Sign In
Buy ABIO
$2.40
+0 (+0%)
At Close: Nov 29, 2024
ARCA Biopharma Announces Third Quarter 2019 Financial Results and Provides Corporate Update
09:10pm, Wednesday, 06'th Nov 2019
PRECISION-AF pivotal Phase 3 clinical trial initiation anticipated first quarter of 2020Trial to examine atrial fibrillation in a heart failure population for which there are no.
Is ARCA biopharma (NASDAQ:ABIO) In A Good Position To Invest In Growth?
01:47pm, Sunday, 03'rd Nov 2019
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
Bitcoin fails to recover as weekly volume on BitMEX drops 72% in 3 months, traders bearish
04:06am, Friday, 18'th Oct 2019
The Bitcoin price has failed to push above a relatively low resistance level at $8,374, making a bigger pullback into the mid-$7,000 region more likely.
Bitcoin volume on BitMEX drops to multi-month low, sparking fears of extended pullback
08:29pm, Monday, 14'th Oct 2019
The volume of bitcoin on BitMEX dropped to a seven-month low on October 12 (Saturday), to below $900 million for the first time since March.
Block.one, Creator of EOS, Settles with the SEC. Was it a Slap on the Wrist? Did EOS Get a Pass from the Feds?
06:38pm, Wednesday, 02'nd Oct 2019
Earlier this week it was announced by the Securities and Exchange Commission (SEC) that it had settled with Block.one, creator of EOS, regarding allegations of issuing unregistered securities during a
Privacy Coins Face Existential Threat Amid Regulatory Pinch - AdvisorHub
06:52pm, Thursday, 19'th Sep 2019
Cryptocurrencies such as Monero, Zcash and Dash, which can to varying degrees obfuscate transactions, are making it harder for exchanges and custodians to comply with fresh international guidelines t
RDC : la Société nationale de l’assurance obtient son agrément
01:39pm, Monday, 16'th Sep 2019
En République démocratique du Congo, l’Autorité de régulation et de contrôle des assurances (Arca) a octroyé début septembre, un agrément à la Société nationale de l’assurance (Sonas) q
ARCA Biopharma President and CEO Dr. Michael Bristow to Present at HFSA 2019 Excellence in Translational Science Symposium
12:30pm, Thursday, 12'th Sep 2019
ARCA biopharma, Inc. (ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for cardiovascular diseases, today announced that Dr. Micha
Arca Biopharma Announces Gencaro Atrial Fibrillation Clinical Data Selected for Presentation at HFSA 2019 Scientific Meeting
12:30pm, Wednesday, 11'th Sep 2019
ARCA biopharma, Inc. (ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for cardiovascular diseases, today announced that Gencaro a
Could The ARCA biopharma, Inc. (NASDAQ:ABIO) Ownership Structure Tell Us Something Useful?
05:37pm, Wednesday, 04'th Sep 2019
A look at the shareholders of ARCA biopharma, Inc. (NASDAQ:ABIO) can tell us which group is most powerful...
